SOURCE: Beleave Inc.

Beleave Inc.

June 05, 2017 20:10 ET

Beleave Inc.: No Material Change

TORONTO, ON--(Marketwired - June 05, 2017) - Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) ("Beleave" or the "Company"), at the request of the Investment Industry Regulatory Organization of Canada ("IRROC"), wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent share price depreciation.

Consistent with the Company's press release dated May 26th, 2017 the Company continues to move forward with all aspects outlined in its above corporate update. Beleave remains committed to being at the forefront of cutting edge collaborative research initiatives and is excited about its ability to commence its first cultivation cycle.

About Beleave

Beleave Inc. is a biotech company and Beleave's wholly-owned subsidiary First Access Medical Inc. ("FAM") is a licensed producer pursuant to the ACMPR. Beleave's purpose-built facility is in Hamilton, Ontario.

Forward-Looking Statements

This news release contains forward-looking information. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking information. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. These risks and uncertainties include, but are not limited to, the Company's ability to satisfy the conditions associated with its cultivation license, the Company's ability to obtain a sales license and the related timing considerations, receiving regulatory approvals in connection with its proposed expansion, the availability of further financing, consumer interest in its products, competition, regulation, operational and technological risks, and anticipated and unanticipated costs and delays. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to several factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.

Contact Information